Evidence map›Paper›PMID 34582666›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2021

Preparing for the Next Pandemic: An Asian National Cancer Centers Alliance (ANCCA) Initiative.

Laureline Gatellier, Sok King Ong, Tomohiro Matsuda, Noraslinah Ramlee, Fen Nee Lau, Suhana Yusak, H R Soeko Werdi Nintindo D, Achmad Mulawarman Jayusman, Ayu Hutami Syarif, Kishor K Pradhananga and 7 more

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

Laureline GatellierNational Cancer Center, Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.ORCID 0000-0002-0331-3235
Sok King OngEarly Detection and Cancer Prevention Services, The Brunei Cancer Centre, Pantai Jerudong Specialist Centre, Brunei Darussalam.
Tomohiro MatsudaNational Cancer Center, Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
Noraslinah RamleeEarly Detection and Cancer Prevention Services, The Brunei Cancer Centre, Pantai Jerudong Specialist Centre, Brunei Darussalam.
Fen Nee LauNational Cancer Institute, 4, Jalan P7, Presint 7, 62250 Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia.
Suhana YusakNational Cancer Institute, 4, Jalan P7, Presint 7, 62250 Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia.
H R Soeko Werdi Nintindo DDharmais Hospital - National Cancer Center, Jalan Letjend S. Parman No.84-86 Kecamatan Palmerah, Kota Jakarta Barat, DKI Jakarta, Indonesia.
Achmad Mulawarman JayusmanDharmais Hospital - National Cancer Center, Jalan Letjend S. Parman No.84-86 Kecamatan Palmerah, Kota Jakarta Barat, DKI Jakarta, Indonesia.
Ayu Hutami SyarifDharmais Hospital - National Cancer Center, Jalan Letjend S. Parman No.84-86 Kecamatan Palmerah, Kota Jakarta Barat, DKI Jakarta, Indonesia.
Kishor K PradhanangaKathmandu Cancer Center, Tathali, Bhaktapur, Nepal.
Aasim YusufShaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.ORCID 0000-0003-1943-2746
Giang Nguyen HuongNational Cancer Institute, National Cancer Hospital, Hanoi, Vietnam.
Manju SengarTata Memorial Centre, Homi Bhabha National Institute, Dr Ernest Borges Rd, Parel, Mumbai, Maharashtra 2, India.
C S PrameshTata Memorial Centre, Homi Bhabha National Institute, Dr Ernest Borges Rd, Parel, Mumbai, Maharashtra 2, India.
Alireza Mosavi JarrahiMedical School, Shahid Behshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8043-9221
Tatsuya SuzukiNational Cancer Center, Japan, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.
William Y HwangNational Cancer Centre of Singapore, 11, Hospital Crescent, Singapore.ORCID 0000-0003-0143-6263
Duke-NUS Medical School · SGKathmandu Cancer CenterShaukat Khanum Memorial Cancer Hospital and Research Center · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-pandemic has shown significant impact on cancer care from early detection, management plan to clinical outcomes of cancer patients. The Asian National Cancer Centres Alliance (ANCCA) has put together the 9 "Ps" as guidelines for cancer programs to better prepare for the next pandemic. The 9 "Ps" are Priority, Protocols and Processes, Patients, People, Personal Protective Equipments (PPEs), Pharmaceuticals, Places, Preparedness, and Politics. Priority: to maintain cancer care as a key priority in the health system response even during a global infectious disease pandemic. Protocol and processes: to develop a set of Standard Operating Procedures (SOPs) and have relevant expertise to man the Disease Outbreak Response (DORS) Taskforce before an outbreak. Patients: to prioritize patient safety in the event of an outbreak and the need to reschedule cancer management plan, supported by tele-consultation and use of artificial intelligence technology. People: to have business continuity planning to support surge capacity. PPEs and Pharmaceuticals: to develop plan for stockpiles management, build local manufacturing capacity and disseminate information on proper use and reduce wastage. Places: to design and build cancer care facilities to cater for the need of triaging, infection control, isolation and segregation. Preparedness: to invest early on manpower building and technology innovations through multisectoral and international collaborations. Politics: to ensure leadership which bring trust, cohesion and solidarity for successful response to pandemic and mitigate negative impact on the healthcare system.

Indexed as

Artificial IntelligenceAsiaCancer Care FacilitiesDelivery of Health CareDisaster PlanningHumansInfection ControlNeoplasmsPandemicsRegional Health PlanningTelemedicineAsiacancer centerCoronaviruspatients

Identifiers

PMID34582666
PMCPMC8850880
OpenAlexW3204360742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.